211 related articles for article (PubMed ID: 15280532)
21. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
Cannon PM; Matthews S; Clark N; Byles ED; Iourin O; Hockley DJ; Kingsman SM; Kingsman AJ
J Virol; 1997 May; 71(5):3474-83. PubMed ID: 9094619
[TBL] [Abstract][Full Text] [Related]
22. The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P
Watanabe SM; Medina GN; Eastep GN; Ghanam RH; Vlach J; Saad JS; Carter CA
J Biol Chem; 2018 Dec; 293(49):18841-18853. PubMed ID: 30309982
[TBL] [Abstract][Full Text] [Related]
23. Functions of the HIV-1 matrix protein p17.
Fiorentini S; Marini E; Caracciolo S; Caruso A
New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA.
Bukrinskaya AG; Vorkunova GK; Tentsov YYu
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1795-801. PubMed ID: 1457192
[TBL] [Abstract][Full Text] [Related]
25. Human Polycomb group EED protein negatively affects HIV-1 assembly and release.
Rakotobe D; Tardy JC; André P; Hong SS; Darlix JL; Boulanger P
Retrovirology; 2007 Jun; 4():37. PubMed ID: 17547741
[TBL] [Abstract][Full Text] [Related]
26. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
[TBL] [Abstract][Full Text] [Related]
27. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes.
Gupta S; Arora K; Gupta A; Chaudhary VK
Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711
[TBL] [Abstract][Full Text] [Related]
28. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
Zhou W; Resh MD
J Virol; 1996 Dec; 70(12):8540-8. PubMed ID: 8970978
[TBL] [Abstract][Full Text] [Related]
29. Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.
Caccuri F; Iaria ML; Campilongo F; Varney K; Rossi A; Mitola S; Schiarea S; Bugatti A; Mazzuca P; Giagulli C; Fiorentini S; Lu W; Salmona M; Caruso A
Sci Rep; 2016 Dec; 6():38027. PubMed ID: 27905556
[TBL] [Abstract][Full Text] [Related]
30. Calmodulin and HIV type 1: interactions with Gag and Gag products.
Radding W; Williams JP; McKenna MA; Tummala R; Hunter E; Tytler EM; McDonald JM
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1519-25. PubMed ID: 11054265
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly.
Vlach J; Eastep GN; Ghanam RH; Watanabe SM; Carter CA; Saad JS
J Biol Chem; 2018 Dec; 293(49):18828-18840. PubMed ID: 30309983
[TBL] [Abstract][Full Text] [Related]
32. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.
Morikawa Y; Zhang WH; Hockley DJ; Nermut MV; Jones IM
J Virol; 1998 Sep; 72(9):7659-63. PubMed ID: 9696871
[TBL] [Abstract][Full Text] [Related]
33. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
34. [HIV-1 assembly is initiated by p17 matrix protein].
Vorkunova GK; Lupandin SI; Bukrinskaia AG
Mol Biol (Mosk); 2011; 45(5):879-83. PubMed ID: 22393785
[TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics analysis of HIV-1 matrix protein: clarifying differences between crystallographic and solution structures.
Verli H; Calazans A; Brindeiro R; Tanuri A; Guimarães JA
J Mol Graph Model; 2007 Jul; 26(1):62-8. PubMed ID: 17067836
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.
Gallay P; Swingler S; Aiken C; Trono D
Cell; 1995 Feb; 80(3):379-88. PubMed ID: 7859280
[TBL] [Abstract][Full Text] [Related]
37. Refined solution structure of p17, the HIV matrix protein.
Matthews S; Barlow P; Clark N; Kingsman S; Kingsman A; Campbell I
Biochem Soc Trans; 1995 Nov; 23(4):725-9. PubMed ID: 8654825
[No Abstract] [Full Text] [Related]
38. Genetic characterization of HIV type 1 gag p17 matrix genes in isolates from infected mothers lacking perinatal transmission.
Hahn T; Ahmad N
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1673-80. PubMed ID: 11779356
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
Fiorentini S; Becker PD; Marini E; Marconi P; Avolio M; Tosti G; Link C; Manservigi R; Guzman CA; Caruso A
Viral Immunol; 2006; 19(2):177-88. PubMed ID: 16817760
[TBL] [Abstract][Full Text] [Related]
40. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
